Hyperuricemia in Pediatric Renal Transplant Recipients

被引:7
|
作者
Gokceoglu, Arife Uslu [1 ]
Akman, Sema [1 ]
Koyun, Mustafa [1 ]
Comak, Elif [1 ]
Dogan, Cagla Serpil [1 ]
Akbas, Halide [2 ]
Dinckan, Ayhan [3 ]
机构
[1] Akdeniz Univ, Fac Med, Dept Pediat Nephrol, TR-07070 Antalya, Turkey
[2] Akdeniz Univ, Fac Med, Dept Biochem, TR-07070 Antalya, Turkey
[3] Akdeniz Univ, Fac Med, Organ Transplantat Inst, TR-07070 Antalya, Turkey
关键词
Hyperuricemia; Tacrolimus; Cyclosporine; URIC-ACID; HYPERTENSION; PREVALENCE; SURVIVAL; DISEASE; COHORT;
D O I
10.6002/ect.2013.0012
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Objectives: We sought to evaluate the prevalence and confounding clinical variables of hyperuricemia in pediatric kidney transplant patients. Materials and Methods: We retrospectively evaluated the medical records of 151 pediatric renal transplant recipients who received their grafts at Akdeniz University Medical Faculty in Antalya, Turkey, with a follow-up longer than 6 months. This retrospective, single-center study included 117 pediatric renal transplant recipients, after we had excluded the patients with changes in immunosuppressive treatment and graft loss, who were receiving therapy with allopurinol and furosemide. Patient information and laboratory data were obtained from patient charts and an electronic hospital database. Results: Mean uric acid levels of patients were 311 +/- 74 mu mol/L, and 24 of all of the patients (20%) had high uric acid levels. Fifteen patients taking tacrolimus (16%), and 9 of patients taking cyclosporine (39%) had hyperuricemia. The hyperuricemia rate of patients taking cyclosporine was significantly higher than it was for those patients taking tacrolimus (P = .014). Mean levels of uric acid in patients taking cyclosporine were higher than those of patients taking tacrolimus (344 +/- 62 mu mol/L and 303 +/- 75 mu mol/L; P = .006). There was a significant positive correlation between mean uric acid concentrations, and both serum creatinine (P = .000; r=0.487) and cystatin C (P = .000; r=0.433). There was negative correlation between mean uric acid concentration and estimated glomerular filtration rate (P = .000; r=-0.417). Mean uric acid levels of patients with intact graft function (estimated glomerular filtration rate >= 60 mL/min/1.73 m(2)) was lower than the patients with a low estimated glomerular filtration rate (291 +/- 67 mu mol/L and 353 +/- 71 mu mol/L; P = .000). Mean uric acid level of patients with normal body mass index was significantly lower than that of patients who were obese-overweight (301 +/- 64 mu mol/L vs 343 +/- 94 mu mol/L; P = .045). Conclusions: We found 20% of our patient group had high uric acid levels. We also found that lower glomerular filtration rate, higher serum creatinine, cystatin c, obesity, and being overweight were risk factors for hyperuricemia in pediatric renal transplant recipients.
引用
收藏
页码:489 / 493
页数:5
相关论文
共 50 条
  • [41] Prevalence and subtypes of BK virus in pediatric renal transplant recipients in Russia
    Momynaliev, K. T.
    Gorbatenko, E. V.
    Shevtsov, A. B.
    Gribanov, O. G.
    Babenko, N. N.
    Kaabak, M. M.
    PEDIATRIC TRANSPLANTATION, 2012, 16 (02) : 151 - 159
  • [42] Cytomegalovirus transmission in pediatric renal transplant recipients during the window period
    Gangopadhyay, Sanhita
    Rampersaud, Howard
    Pelletier, J. Peter R.
    Herman, Lettie
    Goldstein, Steven
    Upadhyay, Kiran
    PEDIATRIC TRANSPLANTATION, 2016, 20 (01) : 172 - 177
  • [43] State-of-the-art immunosuppression protocols for pediatric renal transplant recipients
    Pape, Lars
    PEDIATRIC NEPHROLOGY, 2019, 34 (02) : 187 - 194
  • [44] Immune Profile of Pediatric Renal Transplant Recipients following Alemtuzumab Induction
    De Serres, Sacha A.
    Mfarrej, Bechara G.
    Magee, Ciara N.
    Benitez, Fanny
    Ashoor, Isa
    Sayegh, Mohamed H.
    Harmon, William E.
    Najafian, Nader
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 23 (01): : 174 - 182
  • [45] Alemtuzumab induction with tacrolimus monotherapy in 25 pediatric renal transplant recipients
    Sung, Jennifer
    Barry, John M.
    Jenkins, Randy
    Rozansky, David
    Iragorri, Sandra
    Conlin, Michael
    Al-Uzri, Amira
    PEDIATRIC TRANSPLANTATION, 2013, 17 (08) : 718 - 725
  • [46] Sirolimus as renal and immunological rescue agent in pediatric liver transplant recipients
    Basso, Maria-Sole
    Subramaniam, Pushpa
    Tredger, Mike
    Verma, Anita
    Heaton, Nigel
    Rela, Mohamed
    Mieli-Vergani, Giorgina
    Dhawan, Anil
    PEDIATRIC TRANSPLANTATION, 2011, 15 (07) : 722 - 727
  • [47] Unusual presentations of BK virus infections in pediatric renal transplant recipients
    Drake, Keri A.
    Najera, Lydia
    Reed, Robyn C.
    Verghese, Priya S.
    PEDIATRIC TRANSPLANTATION, 2013, 17 (01) : E9 - E15
  • [48] The Economic Burden of Posttransplant Events in Renal Transplant Recipients in Europe
    Chamberlain, George
    Baboolal, Keshwar
    Bennett, Hayley
    Pockett, Rhys D.
    McEwan, Phil
    Sabater, Javier
    Sennfaelt, Karin
    TRANSPLANTATION, 2014, 97 (08) : 854 - 861
  • [49] Anemia and markers of erythropoiesis in pediatric kidney transplant recipients compared to children with chronic renal failure
    Krause, Irit
    Davidovits, Miriam
    Tamary, Hannah
    Yutcis, Maria
    Dagan, Amit
    PEDIATRIC TRANSPLANTATION, 2016, 20 (07) : 958 - 962
  • [50] Sirolimus pharmacokinetics in pediatric renal transplant recipients receiving calcineurin inhibitor co-therapy
    Schachter, Asher D.
    Benfield, Mark R.
    Wyatt, Robert J.
    Grimm, Paul C.
    Fennell, Robert S.
    Herrin, John T.
    Lirenman, David S.
    McDonald, Ruth A.
    Munoz-Arizpe, Ricardo
    Harmon, William E.
    PEDIATRIC TRANSPLANTATION, 2006, 10 (08) : 914 - 919